223 related articles for article (PubMed ID: 23880761)
1. Progesterone receptor A stability is mediated by glycogen synthase kinase-3β in the Brca1-deficient mammary gland.
Wang S; Li Y; Hsu PH; Lee SY; Kim Y; Lee EYP
J Biol Chem; 2013 Sep; 288(36):26265-26274. PubMed ID: 23880761
[TBL] [Abstract][Full Text] [Related]
2. The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.
Ma Y; Katiyar P; Jones LP; Fan S; Zhang Y; Furth PA; Rosen EM
Mol Endocrinol; 2006 Jan; 20(1):14-34. PubMed ID: 16109739
[TBL] [Abstract][Full Text] [Related]
3. Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist.
Poole AJ; Li Y; Kim Y; Lin SC; Lee WH; Lee EY
Science; 2006 Dec; 314(5804):1467-70. PubMed ID: 17138902
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters.
Calvo V; Beato M
Cancer Res; 2011 May; 71(9):3422-31. PubMed ID: 21531767
[TBL] [Abstract][Full Text] [Related]
5. Selective progesterone receptor blockade prevents BRCA1-associated mouse mammary tumors through modulation of epithelial and stromal genes.
Lee O; Bosland MC; Wang M; Shidfar A; Hosseini O; Xuei X; Patel P; Schipma MJ; Helenowski I; Kim JJ; Clare SE; Khan SA
Cancer Lett; 2021 Nov; 520():255-266. PubMed ID: 34329741
[TBL] [Abstract][Full Text] [Related]
6. Progesterone receptors in mammary gland development and tumorigenesis.
Conneely OM; Jericevic BM; Lydon JP
J Mammary Gland Biol Neoplasia; 2003 Apr; 8(2):205-14. PubMed ID: 14635795
[TBL] [Abstract][Full Text] [Related]
7. The biology of progesterone receptor in the normal mammary gland and in breast cancer.
Obr AE; Edwards DP
Mol Cell Endocrinol; 2012 Jun; 357(1-2):4-17. PubMed ID: 22193050
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development.
Bai F; Chan HL; Scott A; Smith MD; Fan C; Herschkowitz JI; Perou CM; Livingstone AS; Robbins DJ; Capobianco AJ; Pei XH
Cancer Res; 2014 Nov; 74(21):6161-72. PubMed ID: 25239453
[TBL] [Abstract][Full Text] [Related]
9. Promotion of BRCA1-associated triple-negative breast cancer by ovarian hormones.
Lee EY
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):68-73. PubMed ID: 18197009
[TBL] [Abstract][Full Text] [Related]
10. Progesterone regulation of stem and progenitor cells in normal and malignant breast.
Axlund SD; Sartorius CA
Mol Cell Endocrinol; 2012 Jun; 357(1-2):71-9. PubMed ID: 21945473
[TBL] [Abstract][Full Text] [Related]
11. Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development.
Ramamoorthy S; Dhananjayan SC; Demayo FJ; Nawaz Z
Mol Endocrinol; 2010 Nov; 24(11):2099-113. PubMed ID: 20829392
[TBL] [Abstract][Full Text] [Related]
12. BRCA1 mutation influences progesterone response in human benign mammary organoids.
Davaadelger B; Choi MR; Singhal H; Clare SE; Khan SA; Kim JJ
Breast Cancer Res; 2019 Nov; 21(1):124. PubMed ID: 31771627
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 Attenuates Progesterone Effects on Proliferation and NFκB Activation in Normal Human Mammary Epithelial Cells.
Hilton HN; Patterson McDonald LJ; Santucci N; van der Bent FR; Silvestri A; Graham JD; Clarke CL
J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):257-270. PubMed ID: 31104199
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the heterogeneity and tumorigenesis of BRCA1 deficient mammary tumors via single cell RNA sequencing.
Sun H; Zeng J; Miao Z; Lei KC; Huang C; Hu L; Su SM; Chan UI; Miao K; Zhang X; Zhang A; Guo S; Chen S; Meng Y; Deng M; Hao W; Lei H; Lin Y; Yang Z; Tang D; Wong KH; Zhang XD; Xu X; Deng CX
Theranostics; 2021; 11(20):9967-9987. PubMed ID: 34815798
[No Abstract] [Full Text] [Related]
15. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.
Burga LN; Hu H; Juvekar A; Tung NM; Troyan SL; Hofstatter EW; Wulf GM
Breast Cancer Res; 2011 Mar; 13(2):R30. PubMed ID: 21396117
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of prepubertal genistein exposure on mammary tumorigenesis are dependent on BRCA1 expression.
de Assis S; Warri A; Benitez C; Helferich W; Hilakivi-Clarke L
Cancer Prev Res (Phila); 2011 Sep; 4(9):1436-48. PubMed ID: 21680703
[TBL] [Abstract][Full Text] [Related]
17. Progesterone promotes immunomodulation and tumor development in the murine mammary gland.
Werner LR; Gibson KA; Goodman ML; Helm DE; Walter KR; Holloran SM; Trinca GM; Hastings RC; Yang HH; Hu Y; Wei J; Lei G; Yang XY; Madan R; Molinolo AA; Markiewicz MA; Chalise P; Axelrod ML; Balko JM; Hunter KW; Hartman ZC; Lange CA; Hagan CR
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33958486
[TBL] [Abstract][Full Text] [Related]
18. The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression.
Shakya R; Szabolcs M; McCarthy E; Ospina E; Basso K; Nandula S; Murty V; Baer R; Ludwig T
Proc Natl Acad Sci U S A; 2008 May; 105(19):7040-5. PubMed ID: 18443292
[TBL] [Abstract][Full Text] [Related]
19. The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer.
Sampayo R; Recouvreux S; Simian M
Vitam Horm; 2013; 93():185-201. PubMed ID: 23810007
[TBL] [Abstract][Full Text] [Related]
20. BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling.
Verma S; Yeddula N; Soda Y; Zhu Q; Pao G; Moresco J; Diedrich JK; Hong A; Plouffe S; Moroishi T; Guan KL; Verma IM
Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7363-7370. PubMed ID: 30918126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
